0.89
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Yahoo
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio slumps after Q4 miss as Piper Sandler downgrades - MSN
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes - MSN
Canaccord maintains TELA Bio stock with $7 target post-challenges By Investing.com - Investing.com Canada
Canaccord maintains TELA Bio stock with $7 target post-challenges - Investing.com
Tela Bio stock plunges to 52-week low of $1.13 amid market challenges - Investing.com Canada
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 50% - simplywall.st
TELA Bio introduces larger sizes for soft tissue reconstruction - Investing.com India
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - GlobeNewswire
Revolutionary Expansion: TELA Bio's New OviTex PRS Sizes Set Industry Record as Sales Surge 31% - Stock Titan
TELA Bio introduces larger sizes for soft tissue reconstruction By Investing.com - Investing.com UK
TELA Bio’s Earnings Call: Challenges and Optimism for 2025 - MSN
TELA Bio (NASDAQ:TELA) Cut to “Neutral” at Piper Sandler - The AM Reporter
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook - MSN
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $7.00 - Defense World
TELA Bio (NASDAQ:TELA) Rating Lowered to “Neutral” at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA investor three-year losses grow to 88% as the stock sheds US$35m this past week - simplywall.st
TELA Bio Full Year 2024 Earnings: Revenues Disappoint - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript - Insider Monkey
Tela Bio downgraded to Neutral from Overweight at Piper Sandler - TipRanks
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles - Investing.com India
TELA Bio stock price target cut to $7 by Citizens JMP - Investing.com Canada
TELA Bio Inc. (TELA) reports earnings - Quartz
TELA Bio, Inc. SEC 10-K Report - TradingView
Sector Update: Health Care - TradingView
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges - Investing.com India
TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover - Yahoo
TELA Bio’s Hold Rating: Challenges in Sales Force Turnover and Financial Outlook - TipRanks
Tela Bio stock falls as Piper downgrades on Q4 miss (TELA) - Seeking Alpha
Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result - Yahoo Finance
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Tela Bio Q4 2024 misses earnings, stock drops By Investing.com - Investing.com Australia
Canaccord cuts TELA Bio stock target to $7, maintains Buy By Investing.com - Investing.com South Africa
Canaccord cuts TELA Bio stock target to $7, maintains Buy - Investing.com
Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5 - MarketScreener
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):